Healthcare -
Biotechnology - NASDAQ - US
$ 0.3949
-9.12 %
$ 20.6 M
Market Cap
-1.38
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
Cardio Diagnostics Holdings, Inc.
| Revenue | 34.9 K |
| Cost Of Revenue | 276 K |
| Gross Profit | -241 K |
| Operating Expenses | 8.4 M |
| Operating Income | -8.37 M |
| Other Expenses | 17.6 K |
| Net Income | -8.38 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | |
|---|---|---|---|---|---|
| REVENUE | |||||
| Revenue | 34.9 K | 17.1 K | 950 | 901 | 0 |
| GROSS PROFIT | |||||
| Cost Of Revenue | 0.3 | 0 | 16 K | 0 | 0 |
| Gross Profit | (0.2) | 17.1 K | 15 K | 901 | 0 |
| OPERATING INCOME | |||||
| Operating Expenses | 8.4 | 7.3 | 4.5 | 0.6 | 0.6 |
| Selling, General and Administrative Expenses | 8.4 | 7.1 | 4.5 | 0.6 | 0.6 |
| Research and Development Expenses | 29.1 K | 0.1 | 40.4 K | 31.5 K | 1.5 K |
| Operating Income | (8.4) | (7.2) | (4.5) | (0.6) | (0.6) |
| PRE-TAX INCOME | |||||
| Interest Income Expense | 18.6 K | 6.7 | 0 | 0 | 0 |
| Total Other Income | 17.6 K | (1.1) | (0.1) | 0 | 4 K |
| Pre-Tax Income | (8.4) | (8.4) | (4.7) | (0.6) | (0.6) |
| NET INCOME | |||||
| Tax Provision | 0 | 0 | 0.1 | 2 | 0 |
| Net Income | (8.4) | (8.4) | (4.7) | (0.6) | (0.6) |
| EPS | 0.34 | 0.66 | 1.51 | 0.53 | 0.0636 |